IntelliCyt Corporation was named winner of the Best Technology Award at ELRIG UK’s recent 4th Annual Pharmaceutical Flow Cytometry & Imaging meeting held at GlaxoSmithKline, Ware, United Kingdom.
Scientific delegates at the event had been asked to nominate “the most interesting / innovative technology you have seen at the exhibition”, and voted for the technology which deserved the ELRIG’s Best Technology Award.
“This award is a source of great pride at IntelliCyt and we are honored that the scientists at ELRIG recognize the capabilities the iQue® Screener provides in immunology, antibody discovery, and drug discovery screening” said R. Terry Dunlay, President and CEO. He continued, “we are proud to have developed this novel technology that remains unsurpassed in its capabilities for rapid, accurate, and cost effective screening of large numbers cell and bead-based samples in 96-, 384-, and 1536-well microplates,”
“In the past we used standard flow cytometers, but the lack of real high-throughput capacity meant that we needed to split up one screening experiment over multiple days, which meant an increase in man hours and prolonged timelines. The iQue Screener is able to generate the same data, but up to 20 times faster. The whole system very intuitive and simple to use, so there is no need to send staff on expensive training courses or have dedicated instrument operators,” said Brecht Hoedemaekers, Project Manager, ImmunXperts.
ELRIG’s 4th bi-annual event, held at the Sir David Jack Conference Centre in Ware proved to be as popular as ever with almost 300 delegates registered. Thirty three companies were represented in the trade show and there was some very impressive technology and products on display. The technology prize, voted for by the delegates was hotly competed with Intellicyt winning overall with their “iQue”.